| News
The pharma centers of Basel and India are influencing each other
21.02.2020
Basel has long been one of the world’s most important locations within the pharmaceutical industry. But pharma firms are now starting to play an even bigger role in India as well. Both locations are influencing each other, as shown by the recently ended BioAsia event.

Anke Hollnagel, Director Asia at BaselArea.swiss
Large Indian pharma companies are currently focusing on generics and biosimilars in particular, while Basel-based firms such as Novartis and Roche carry out large-scale research projects, as detailed in a guest article on swissinfo.ch by Anke Hollnagel, Director Asia of the local business promotion organization BaselArea.swiss. However, there are also parallels and mutually beneficial influences between the two locations.
In this way, four startups based in Basel – namely Cellestia, Bottmedical, Artidis und Noul – presented their businesses within the framework of the BioAsia India event, which was held in Hyderabad on February 17-20, 2020. The Swiss delegation came at the initiative of Switzerland Global Enterprise (S-GE), a Swiss foreign trade promotion organization. The delegation also included representatives from BaselArea.swiss, which promoted the economic area of Basel at the event.
However, the interest is ever stronger in the other direction, as Anke Hollnagel notes in her article. In this context, Basel is becoming an attractive location for ever more Indian firms. These companies are active particularly in the areas of the Internet of Things (IoT), Artificial Intelligence (AI) and Machine Learning, and they are offering their services to Basel-based firms operating in the field of life sciences. In this way, they are driving the development of the life sciences sector towards digital healthcare and data-led personalized medicine. According to Anke Hollnagel, this influence will increase yet further over the coming years as Indian firms develop. The major Indian pharma group Dr. Reddy’s has already established a strong presence in Basel.
BaselArea.swiss recognized this development a long time ago and has placed a stronger focus on the Indian market in the past year. This focus will be sustained throughout 2020 as well.
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Space Pharmaceuticals establishes presence in Basel
Space Pharmaceuticals AG is strengthening the life sciences cluster in the Basel Area. At its research lab, the cheminformatics company...
Read MoreNextImmune to benefit from Venture Kick financing
The startup accelerator Venture Kick is supporting NextImmune with financing in the amount of 150,000 Swiss francs. The spin-off from...
Read MoreOECD impressed by the canton of Jura’s innovation system
The OECD has examined the innovation systems in place in rural areas of its member states, including the canton of...
Read Moreti&m opens branch in Basel
ti&m now has an office in Basel. With this action, the company specializing in digitization, security and innovation projects is...
Read MoreWhat can artificial intelligence do for health?
Algorithms help diagnose and treat diseases, discover new drugs and personalize prevention. Thus, the potential of artificial intelligence has been...
Read MoreEconomic promotion agency creates 55 new jobs in Jura
The economic promotion agency of the canton of Jura supported a total of 26 companies in founding, establishing a presence...
Read MoreInvestors top up capital of BioVersys
BioVersys has raised 24.2 million Swiss francs in a series C funding round. The Basel-based pharmaceutical company plans to use...
Read MoreSwiss made software label awarded to 1000th company
Swiss made software GmbH has now awarded its seal of quality to its 1,000th member firm. The “swiss made software”...
Read MoreEvokAI to acquire Advancience
EvokAI Creative Labs Inc. has agreed a deal to acquire Advancience. The diagnosis profiles enhanced by Artificial Intelligence (AI) developed...
Read MoreBeiGene opens European headquarters in Basel
BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build...
Read More